CoChat

Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia

Open access
Gurbatri, Candice R., Radford, Georgette A., Vrbanac, Laura, Im, Jongwon, Thomas, Elaine M., Coker, Courtney, Taylor, Samuel R., Jang, YoungUk, Sivan, Ayelet, Rhee, Kyu, Saleh, Anas A., Chien, Tiffany, Zandkarimi, Fereshteh, Lia, Ioana, Lannagan, Tamsin R. M., Wang, Tongtong, Wright, Josephine A., Kobayashi, Hiroki, Ng, Jia Q., Lawrence, Matt, Sammour, Tarik, Thomas, Michelle, Lewis, Mark, Papanicolas, Lito, Perry, Joanne, Fitzsimmons, Tracy, Kaazan, Patricia, Lim, Amanda, Stavropoulos, Alexandra M., Gouskos, Dion A., Marker, Julie, Ostroff, Cheri, Rogers, Geraint, Arpaia, Nicholas, Worthley, Daniel L., Woods, Susan L., Danino, Tal · 2024 · Nature Communications
Cited by 199

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Bioengineered probiotics enable new opportunities to improve colorectal cancer (CRC) screening, prevention and treatment. Here, first, we demonstrate selective colonization of colorectal adenomas after oral delivery of probiotic E. coli Nissle 1917 (EcN) to a genetically-engineered murine model of CRC predisposition and orthotopic models of CRC. We next undertake an interventional, double-blind, dual-centre, prospective clinical trial, in which CRC patients take either placebo or EcN for two weeks prior to resection of neoplastic and adjacent normal colorectal tissue (ACTRN12619000210178). We detect enrichment of EcN in tumor samples over normal tissue from probiotic-treated patients (primary outcome of the trial). Next, we develop early CRC intervention strategies. To detect lesions, we engineer EcN to produce a small molecule, salicylate. Oral delivery of this strain results in increased levels of salicylate in the urine of adenoma-bearing mice, in comparison to healthy controls. To assess therapeutic potential, we engineer EcN to locally release a cytokine, GM-CSF, and blocking nanobodies against PD-L1 and CTLA-4 at the neoplastic site, and demonstrate that oral delivery of this strain reduces adenoma burden by ~50%. Together, these results support the use of EcN as an orally-deliverable platform to detect disease and treat CRC through the production of screening and therapeutic molecules.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-024-44776-4

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 16 references

Cited by

See all 199

Metadata

Authors
Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K., Saleh, A. A., Chien, T., Zandkarimi, F., Lia, I., Lannagan, T. R. M., Wang, T., Wright, J. A., Kobayashi, H., Ng, J. Q., Lawrence, M., Sammour, T., Thomas, M., Lewis, M., Papanicolas, L., Perry, J., Fitzsimmons, T., Kaazan, P., Lim, A., Stavropoulos, A. M., Gouskos, D. A., Marker, J., Ostroff, C., Rogers, G., Arpaia, N., Worthley, D. L., Woods, S. L., & Danino, T.
Venue
Nature Communications
Published
2024-01-20
Volume
15
Issue
1
Pages
646-646
ISSN
2041-1723 (ISSN-L)
OpenAlex
W4391044494
Cited by
199
References
16
FWCI
33.06
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. https://app.cochat.ai/papers/10.1038/s41467-024-44776-4
The paper
Gurbatri, C. R., Radford, G. A., Vrbanac, L., Im, J., Thomas, E. M., Coker, C., Taylor, S. R., Jang, Y., Sivan, A., Rhee, K., Saleh, A. A., Chien, T., Zandkarimi, F., Lia, I., Lannagan, T. R. M., Wang, T., Wright, J. A., Kobayashi, H., Ng, J. Q., . . . Danino, T. (2024). Engineering tumor-colonizing E. coli Nissle 1917 for detection and treatment of colorectal neoplasia. Nature Communications. https://doi.org/10.1038/s41467-024-44776-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.